Explore
Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics
0 Ungluers have
Faved this Work
Login to Fave
Thanks to the breast cancer research of recent decades, effective methods and strategies have been established, allowing the mortality rates of breast cancer patients to decrease more and more. However, we still face many challenges. The role of certain biomarkers or mutations is still not clear for treatment and surveillance. Novel drugs are often associated with a different spectrum of adverse events than that seen for conventional therapies, accordingly having an impact on patients’ compliance behaviors. In breast cancer surgery, in some cases, the question remains whether to escalate or deescalate. Additionally, with regard to diagnostics, in a digitalized world, home-based tools and therapy monitoring options are of high importance, especially under the tough conditions and supply problems seen during the COVID-19 pandemic.This Special Issue gathers original research articles and reviews demonstrating therapeutic challenges, current research strategies, and novel diagnostics in breast cancer.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 41 times via unglue.it ebook links.
- 41 - pdf (CC BY) at Unglue.it.
Keywords
- 18F-FES PET/CT
- 18F-fluorodeoxyglucose positron emission tomography/computed tomography
- abemaciclib
- Adenosine
- advanced breast cancer
- Average Glandular Dose
- bounce
- Breast cancer
- breast cancer screening
- breast cancer susceptibility genes 1 and 2
- cancer side effects
- CDK4/6 inhibitor
- chemotherapy
- cognitive impairment
- contrast-enhanced mammography
- coping self-efficacy
- dalpiciclib
- Diagnosis
- digital breast tomosynthesis
- drug resistance
- endocrine treatment
- ER heterogeneity
- ERK
- fear of cancer recurrence
- Genetic Testing
- HER2
- heterogeneity
- hormone receptor
- human epidermal growth factor receptor 2
- human epidermal growth factor receptor 2—negative
- individualized therapy
- intraoperative ultrasound
- latent growth modeling
- LEMD1
- localization technique
- lymph node metastasis
- Machine learning
- magnetic seed
- medicine
- metastasis
- metastatic breast cancer
- n/a
- nanocarriers
- neoadjuvant systemic treatment
- Neutrophils
- non-palpable lesion
- oncology
- Oncotype Dx
- palbociclib
- pannexin 1 (PANX1)
- Phytochemicals
- poly(adenosine diphosphate-ribose) polymerase inhibitors
- psychological well-being
- pyrotinib
- radar reflector
- radioactive seed
- radiofrequency identification tag
- real-world
- recurrence score
- registries
- Rehabilitation
- ribociclib
- Risk assessment
- risk prediction models
- risk-based screening
- Telemedicine
- telerehabilitation
- Therapeutic target
- therapy response
- TNBC
- trajectories
- Treatment
- treatment pattern
- tumor microenvironment (TME)
- wire-guided localization
Links
DOI: 10.3390/books978-3-0365-9442-2Editions